Pioglitazone and Lenalidomide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Pioglitazone (pioglitazone hydrochloride) and Lenalidomide (lenalidomide). Common drug interactions include anaemia among females and septic shock among males.

The phase IV clinical study analyzes what interactions people have when they take Pioglitazone and Lenalidomide. It is created by eHealthMe based on reports of 54 people who take the same drugs from the FDA, and is updated regularly.

What is Pioglitazone?

Pioglitazone has active ingredients of pioglitazone hydrochloride. It is often used in diabetes. eHealthMe is studying from 12,864 Pioglitazone users. Check the latest studies of Pioglitazone.

What is Lenalidomide?

Lenalidomide has active ingredients of lenalidomide. eHealthMe is studying from 52,881 Lenalidomide users. Check the latest studies of Lenalidomide.



On Aug, 11, 2026

54 people who take Pioglitazone and Lenalidomide together, and have interactions are studied.

Pioglitazone and Lenalidomide drug interactions.

What are the common drug interactions of Pioglitazone and Lenalidomide, by gender? *:

female:

  1. Anaemia (lack of blood)
  2. Hypotension (abnormally low blood pressure)
  3. Platelet count decreased
  4. Pneumonia
  5. Syncope (loss of consciousness with an inability to maintain postural tone)
  6. Thrombosis (formation of a blood clot inside a blood vessel)
  7. Parainfluenzae virus infection
  8. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  9. Diarrhoea
  10. Muscle spasms (muscle contraction)

male:

  1. Septic shock (shock due to blood infection)
  2. Hepatic enzyme increased
  3. Blood calcium decreased
  4. Blood creatinine increased
  5. Dyspepsia (indigestion)
  6. Erythema (redness of the skin)
  7. Fatigue (feeling of tiredness)
  8. Full blood count decreased
  9. Haemoglobin decreased
  10. Headache (pain in head)

What are the common drug interactions of Pioglitazone and Lenalidomide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Erythema (redness of the skin)
  2. Hypoglycaemia (deficiency of glucose in the bloodstream)
  3. Hypotension (abnormally low blood pressure)
  4. Joint warmth
  5. Pneumonia
  6. Pulmonary embolism (blockage of the main artery of the lung)
  7. Rash pruritic (redness with itching)
  8. Renal failure (kidney dysfunction)
  9. Urinary tract infection

60+:

  1. Hypotension (abnormally low blood pressure)
  2. Anaemia (lack of blood)
  3. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  4. Diarrhoea
  5. Eosinophilia (eosinophil count in the peripheral blood exceeds)
  6. Fatigue (feeling of tiredness)
  7. Renal failure (kidney dysfunction)
  8. Renal failure acute (rapid kidney dysfunction)
  9. White blood cell count decreased
  10. Tachycardia (a heart rate that exceeds the range of 100 beats/min)

What are the existing conditions these people have? *

  1. Multiple Myeloma (cancer of the plasma cells): 29 people, 53.70%
  2. Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 11 people, 20.37%
  3. Mucosal Inflammation (infection of mucous membrane): 11 people, 20.37%
  4. Insomnia (sleeplessness): 11 people, 20.37%
  5. Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 11 people, 20.37%
  6. Mantle Cell Lymphoma (cancer of lymphocytes, a type of white blood cell): 4 people, 7.41%
  7. Type 2 Diabetes: 3 people, 5.56%
  8. Osteoporosis Post-Menopausal (weak bone with possibility to break after stopped menstrual cycles): 3 people, 5.56%
  9. Cough: 3 people, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Pioglitazone and Lenalidomide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Pioglitazone and Lenalidomide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Pioglitazone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Lenalidomide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Pioglitazone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lenalidomide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on pioglitazone hydrochloride and lenalidomide (the active ingredients of Pioglitazone and Lenalidomide, respectively), and Pioglitazone and Lenalidomide (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: